Chi-Lin Ho¹, *Chun-Hsien Chu¹ (1. Institute of Molecular Medicine, National Cheng Kung University)

*岩田 圭子¹、松﨑 秀夫²、野口 雅史¹、新谷 紀人¹ (1. 和歌山県立医科大学、2. 福井大・子どもセ)

*後藤 仁志¹、石山 政仁¹、大江 総一²、野村 真^1,3、北田 容章²、小野 勝彦¹ (1. 京都府立医科大学大学院医学研究科、2. 関西医科大学解剖学、3. 京都工業繊維大学応用生物学)

*Bolati Wulaer¹, Mika Holtz¹, Hideaki Kubotera¹, Toshihiro Endo², Eiji Shigetomi^3,4, Maiko Ono⁵, Schuichi Koizumi^3,4, Yuki Sugiura⁶, Yuhei Takado⁵, Jun Nagai¹ (1. RIKEN Center for Brain Science, Saitama, Japan, 2. Phenovance Research and Technology LLC, Chiba, Japan, 3. Department of Neuropharmacology, Interdisciplinary Graduate School of Medicine, University of Yamanashi, Yamanashi, 4. GLIA Center, University of Yamanashi, Yamanashi, 5. Institute for Quantum Life Science, National Institutes for Quantum Science and Technology, Chiba, Japan , 6. Center for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine, Kyoto, Japan)